chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chief Concern: This patient contacted the Vaccine Healthcare Center to inquire about possible adverse events related to his receipt of the anthrax vaccine. He is a dentist. He contacted the VHC for a causality assessment as to whether receipt of the anthrax vaccine could be causally associated to his development of marginal B-cell lymphoma. History of present illness: The patient is a 40 year old male. He received 3 doses of the anthrax vaccine 2 weeks apart in July and Aug of 2000. He received the typhoid Vi vaccine with AVA #1. He states he does not remember any reaction or untoward symptoms after any of the doses. He believes he had all 3 doses in the triceps of the left arm. Records state he received influenza vaccine in the fall of 2001 and 2002 but no additional vaccines. One year after receiving anthrax #1-3. The papules were pruritic; they would come and go and would last about 7-14 days. There seemed to be no pattern to their reoccurrence. He initially ignored the outbreaks but ultimately did seek medical evaluation in 2000-03 and was told they were "hives". No treatment was prescribed but he occasionally took BENADRYL for the itching which did not relieve the symptoms. He then systematically eliminated detergents, soaps, starch, dry cleaning, alcohol, and certain foods including raw fish in the attempts to discover the etiology of the rash. None of these variables seemed to be related but the periodic outbreaks continued for the next 10 years. The papules became erythematous and continued to be self-limiting. In June 2011 he developed a granulomatous lesion on the left arm in the same place as the anthrax injections and his recurrent rash. The lesion was 10 x 30 mm, persistent, red, pruritic, but not accompanied by the usual rash on his back and chest. Through biopsy the lesion was diagnosed as marginal B-cell lymphoma. He was given topical steroids which had no effect followed by injectable steroids which resolved the lesion. He was seen by both dermatology and oncology specialties. Blood tests, marrow biopsy, endoscopy, CT and PET scans were all negative. In 2013 he had a recurrence of a larger lesion - about 1-2 inches in diameter - on the lower inside calf - which also was determined to be marginal B-cell lymphoma. Dermatology used injectable steroids which again resolved the lesion. Systemic symptoms he continues to develop the original pruritic erythematous papules approximately 1-2 x year managed by topical and injectable steroids. Low dose radiation may be considered. Past medical/surgical history: Reported: Past medical history no medical problems, no allergies, no asthma - no chronic medications, no smoking, no alcohol. Family history: Family medical history Mother- diabetes type 2, Father- ulcers resulting in gastric resection. PGF: colon cancer in his early 40. Children healthy. Marginal Zone B-cell lymphoma of mucosa associated lymphoid tissue extranodal.
Screaming headache, extreme myalgia, fatigue until about 5pm on 7/2/19
All of the face paralyzed immediately after getting the shot; Tongue was numb; A report was received from a nurse concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273)and experienced  the serious adverse event of whole face paralyzed and tongue numbness.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unspecified date, the patient received their first of two planned doses of mRNA-1273 (Lot number unknown) intramuscularly for prophylaxis of COVID-19 infection.   The reporter experienced facial numbness after 30 minutes of receiving the vaccine and mentioned two other patients that suffered the same adverse event. This case was to document the event for one of those other patients. This patient had all of the face paralyzed immediately after vaccination. The tongue was also numb. No treatment information was provided.   Action taken with mRNA-1273 in response to the event(s) was not reported.   The outcome of the events was unknown.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt recv vax on 2/2/99; on 2/3/99 pt exp swollen, red, itchy, hot arm from shoulder to vax site
I started to develop an odd headache that I have never had before.  It didn?t  happen until 6 months after the vaccine. It was on the Left side of my forehead. Touching the left side forehead feels very sensitive, like when clothing touches your skin when you have the flu. For awhile, a headache would radiate throughout my head and turn into severe migraines. That has calmed down, but the forehead is still sensitive and remains constant on my left forehead.  In trying to understand this headache, my doctor noticed my autoimmune thyroid was significantly off balance (also possibly triggered by the vaccine). I have vitiligo due to my autoimmune thyroid, which has gotten much worse since the vaccine. All three could be related and possibly triggered by the vaccine. I felt good before the vaccine and my thyroid was stable. I?m waiting on the results of an mri, since the headache is now chronic and continual since october 2021.
Pt. had redness around the nape of her neck and her ears earlier the  morning following the vaccinations.  No other symptoms at that time, 6 hours later I have noticed hives. A few on her neck and some on her lower back.  I gave her Benadryl at 8:30 Friday ( day after vaccine) night and she was rash free the next morning but then around 3:30pm it came back and it was odd because it was red almost opposite of where it was red the day before.  It appeared to me to look like a chemical burn from the inside out. I would like to share photos if able.
seen in out of town ER 15OCT98 w/dx of cellulitis of lt upper arm;tx w/keflex;
Reported hives and cough.  Seen in ER and was given Benadryl.  Had uncontrollable crying in evening.
Fussy since 5/18/11 evening. 2 episodes of bloody stools on 5/19/11.
Redness, irritation on left thigh 5 in by 3.75 in. Pt. examined 2 days after given Varicella given antihistamine for treatment.
Approx 2 minutes after injection, pt c/o dizziness, shortness of breath and palpitations. BP 230/88. HR 123, R 22, POx=98%. Pt became anxious, was transferred to hospital after 20 minutes. At ER pt given Benadryl, Lopressor, Ativan, Pepcid. Released 5-6 hours later.
HOT FLASHES; SHAKY LEGS; NUMBNESS FROM HEAD TO TOE; DIZZINESS; HIGH BLOOD PRESSURE ( 140/90); FEVER; LETHARGY; SLEEPINESS; BODY PAIN; HEADACHE; MUSCLE PAIN IN ARM; This spontaneous report received from a patient concerned a 37 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcoholic, and non smoker, and other pre-existing medical conditions included patient had no known drug allergies. patient had no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031 and expiry: unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced muscle pain in arm. On 11-APR-2021, the subject experienced lethargy. On 11-APR-2021, the subject experienced sleepiness. On 11-APR-2021, the subject experienced body pain. On 11-APR-2021, the subject experienced fever. On 11-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced hot flashes. On 12-APR-2021, the subject experienced shaky legs. On 12-APR-2021, the subject experienced numbness from head to toe. On 12-APR-2021, the subject experienced dizziness. On 12-APR-2021, the subject experienced high blood pressure (140/90). Laboratory data included: Blood pressure (NR: not provided) 140/90. Treatment medications (dates unspecified) included: Paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscle pain in arm, fever, lethargy, sleepiness, hot flashes, shaky legs, numbness from head to toe, dizziness, high blood pressure (140/90), headache and body pain was not reported. This report was non-serious.
Headache, Myalgia, Fever, Diarrhea, NauseaVomiting, Chills Narrative:
Localized soreness, redness, warm to touch. IBU 400 mg bid x 1 day.
Pt had immediate red, blotchy, rash around DTaP shot site. He had been grabbing @ arm as well. Pt was given Motrin and Benadryl and sx began to clear within minutes.
This spontaneous report was received from a medical assistant refers to a 17 year old male patient. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported. On 02-MAR-2018, the patient was vaccinated with improperly stored GARDASIL 9 (dose, units, frequency and route not reported) (lot# N020353, expiration date: 28-APR-2020 and lot # N017686, expiration date: 02-FEB-2020) at a temperature from 47 Fahrenheit (F) to 77 F for 21 hours 45 minutes. No adverse effects were reported. No previous temperature excursion was occurred to the vaccine GARDASIL 9. Data logger was involved. No product quality complaint was involved. This is one of 4 reports received from the same reporter.  Sender's Comments: US-009507513-1803USA004556: US-009507513-1803USA005945: US-009507513-1803USA005947.
heavy sweating, then passed out twice ,hitting the floor  5    hours  after getting shot .    went to summa ed  the next day  ,  cat scan,bloodwork and ekg  came back ok.   on jan 16th i went to a dentist for a abscessed tooth.after i passed out i had a headache for 2 days and felt out of sorts.
I started having heart palpatations, and I kept on doing my normal daily activities. Later that day I felt another set of heart palpatations and I started my relaxation breathing and it helped.
IN THE EVENING FOLLOWING THE VACCINATION, AN INJECTION SITE REACTION OCCURRED AND A RASH DEVELOPED ALL OVER THE PATIENT'S BODY (NECK TO LEGS). HER SKIN WAS VERY ITCHY AND RAW THAT SHE HAD TO GO TO THE EMERGENCY DEPARTMENT WHERE SHE RECEIVED PREDNISONE AND OTHER MEDICATIONS. THE PREDNISONE HELPED WITH THE ITCHINESS, BUT THE PATIENT'S PRIMARY CARE PHYSICIAN REFERRED HER TO AN ALLERGIST WHO WAS NOT ABLE TO HELP, AND SUBSEQUENTLY REFERRED HER TO A DERMATOLOGIST WHO HAS MANAGED THE RASH VERY WELL WITH TOPICAL STEROIDS, HYDROXYZINE AND ORAL PREDNISONE. TO DATE THE PATIENT IS RECEIVING SAID MEDICATIONS, AND RASH HAS RESOLVED. AS PER THE PATIENT, SHE DID NOT HAVE ANY SKIN RASHES OR REACTIONS PREVIOUS TO RECEIVING THE VACCINE.  SHE WAS PROPERLY MONITORED AFTER THE VACCINE AND DID NOT PRESENT WITH A REACTION WHILE BEING MONITORED FOR THE 15-30 MINUTE PERIOD.
Patient received RabAvert day 3 injection in the left gluteus instead of the deltoid. The manufacturer for RabAvert recommends administration into the deltoid for adults or the anterolateral zone of the thigh for infants/small children. The gluteal area should be avoided due to lower neutralizing antibody titers. The agency states that doses administered in the gluteus are not considered valid and must be repeated.
After my Johnson & Johnson vaccine, the following day I developed a red, diffuse in radius size (like a spider bite) rash that is warm to touch and very painful. I am still in pain, the site has some color to it and will be having an appointment with my PCP on 03-11-2021.
Felt fine the first ten min.  I have food allergies so I waited the full 20 min.  Got up and felt al ittle light headed.  By the time I walked to my car I could feel my throat instantly swell.  I drove my self straight to the emergamcy room.  Emergancy room instanly treat me for anaphylactic shock.  I recieved two EPI and was observed there after for the rest of the evening.  Was also giving benadyl as well.  I was dishcharged with EPI and benadryl to take home.  Since I have been home I have had to throat swell everyday and have to take bendrly.  I am not experiencing, muscle weakness all over my body and I'm making an apt. with my main doctor.
Nutcracker syndrome; Bruising; Night sweat; Diarrhea; Nausea over a year; Vomiting; Headaches; Body aches; Fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of RENAL VEIN COMPRESSION (Nutcracker syndrome) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced RENAL VEIN COMPRESSION (Nutcracker syndrome) (seriousness criterion medically significant), CONTUSION (Bruising), NIGHT SWEATS (Night sweat), DIARRHOEA (Diarrhea), NAUSEA (Nausea over a year), VOMITING (Vomiting), HEADACHE (Headaches), PAIN (Body aches) and FATIGUE (Fatigue). At the time of the report, RENAL VEIN COMPRESSION (Nutcracker syndrome), CONTUSION (Bruising), NIGHT SWEATS (Night sweat), DIARRHOEA (Diarrhea), NAUSEA (Nausea over a year), VOMITING (Vomiting), HEADACHE (Headaches), PAIN (Body aches) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not reported.  Company Comment: This spontaneous case concerns a female patient of unknown age with no medical history information reported who experienced the unexpected, serious (medically significant) event of Renal vein compression which occurred on unknown interval after receiving an unknown dose number of mRNA-1273. It was reported that patient has been experiencing nutcracker syndrome along with non-serious events of diarrhea, night sweat, headaches, body aches, bruising, vomiting, nausea, and fatigue for more than a year since receiving the vaccine. The clinical course, diagnostic evaluation and treatment information were not provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a female patient of unknown age with no medical history information reported who experienced the unexpected, serious (medically significant) event of Renal vein compression which occurred on unknown interval after receiving an unknown dose number of mRNA-1273. It was reported that patient has been experiencing nutcracker syndrome along with non-serious events of diarrhea, night sweat, headaches, body aches, bruising, vomiting, nausea, and fatigue for more than a year since receiving the vaccine. The clinical course, diagnostic evaluation and treatment information were not provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.
This spontaneous report has been received from a consumer (aunt of the patient) regarding the female patient of unknown age. Pertinent medical history and drug allergies were not reported. On an unknown date the patient was vaccinated with GARDASIL injection (dose/ dose in series/ route unknown). Concomitant medications were not reported. On an unknown date the patient experienced rheumatoid arthritis, heart palpitations and headaches. The outcome of rheumatoid arthritis, headaches and heart palpitations was reported as not resolved. This is one of several reports received from the same reporter. Additional information has been requested.
On monday night Jan 11 after the covid vaccine shot i had a runny nose and flem.  i also felt muscle aches and very tired and disoriented. the symptoms continued through the week.  on Wed i got covid tested and the results were positive.  i began to have light chills through the week but no fever.   on Jan 15-16 my symptoms peaked and i had a low grade fever and diarrhea for 2 days.  i also developed a rash on my tighs and torso.  on Jan 19 my fever went away along with my other symptoms except for an occasional flem cough.
"Pt presented to Clinic for her vaccine. Post vaccine, pt was feeling faint/weak and was pale. Pt sts feeling short of breath prior to arrival. Pt has hx of lung cancer. Pt was drained last at home on 3/14 per pt husband. EMS performed 12 lead and checked vitals. Pt color improved upon lying on stretcher for a few minutes. Pt's pulmonologist was contacted to see if they want her to go to her appointment scheduled at 1330 or to be transported to ED. Pt. was then transported via EMS to ED." Pt was inpt from 3/18/21 - 3/21/21 with diagnosis of E. Coli bacteremia, recurrent left pleural effusion with drain in place, resolved hypoxia on oxygen, follicular non Hodgkin's lymphoma, pancytopenia, poor appetite, insomnia.  Patient was started on cefepime and then Rocephin per Infectious Disease team but she continued to the duration of this admission until ultimately transitioning her to oral antibiotics with Cipro twice daily to complete 7 day course from 03/19; this prescription was sent to her pharmacy upon discharge.  Discharged home with hospice services (per pt /family preference) for comfort care
Fever/fever of 99.0 F; Pain/Soreness; This case was reported by a consumer via call center representative and described the occurrence of fever in a 84-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th September 2020, the patient received the 1st dose of Shingrix (intramuscular). On 28th September 2020, less than a day after receiving Shingrix, the patient experienced fever and pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever was not recovered/not resolved and the outcome of the pain was unknown.   It was unknown if the reporter considered the fever and pain to be related to Shingrix.  Additional details were provided as follows:  The patient experienced pain and fever after first Shingrix vaccine. The reporter stated, the soreness started after receiving the injection. On 29th September 2020, the patient experienced fever of 99.0 degree F The patient has taken Tylenol, but the fever has not disappeared. All information was not available. The reporter did not consent to follow-up.
1st dose in series given as a booster dose 0.25ml not full dose 0.5ml
Increased swelling, pain, inflammation, and hotness of left upper arm (injection site), nausea, and eventually involvement of left elbow and shoulder---skin resembled orange-peel texture---requiring ER visit at 4:00 AM om 08/31/2012 for dx and tx of cellulitis. Prescriptions for prednisone and cephalexin eventually relieved symptoms after a week.
8/10/21: COVID pos 8/16/21: present to ED with SOB started on steroids and remdesivir 8/22/21: discharged to home on above meds and oxygen 8/23/21: re-admitted and continues to worsen with worsening CXR
1) Extremely sleepy - began the same evening as vaccination (5/7/21) and continues through current date and time - fell asleep on the job while  operating forklift the following night (5/8/2021); 2) Eyesight has worsened (depth perception, double vision) - began within a couple days of vaccine and continues through current date and time - had eye exam (5/18/21) needed new prescription - previously always near-sighted, now needs bi-focals; 3) Confusion/lack of concentration - began 5/9/21 and continues through current date and time; 4) Abnormally "lazy"/unmotivated - began 5/9/21 and continues through current date and time; 5) Little interest in sexual relations  -  began 5/9/21 and continues through current date and time; 6) Seems distant/ somewhat despondent  - began 5/9/21 and continues through current date and time; 7) Generally speaking he is not himself
On March 4 patient experienced vomiting. Early morning March 5 he fell and landed on his hip after being disoriented and experienced aches, weakness, and nausea without vomiting throughout the day. On March 6 he experienced excruciating pain in his left hip and went to the local emergency room following guidance from his primary care physician. He was diagnosed with fluid near his hip joint at the hospital and was discharged the same day. The next day, March 7 he was still in pain but able to walk with assistance. On March 8 he got an x-ray from an orthopedic physician and severe arthritis was found. March 10 the severe pain persisted, but he was able to walk with a walker. On March 12 he received a cortisone shot and required emergency medical assistance to get into a personal vehicle with a family member who drove to the appointment. The next few days, the pain persisted, became worse, and spread throughout his body. On March 16 he was transported by emergency medical services to the local emergency room for treatment and was diagnosed with sepsis and pneumonia. On March 18 he was still being treated when he experienced cardiac arrest while being intubated. He was resuscitated and was on a ventilator being treated for a few more days but ultimately succumbed to sepsis on March 30.
This spontaneous report was received from a pharmacist and refers to a 76-year-old male patient. No information regarding the patient's medical history, concomitant medications and concurrent conditions was provided. On 24-JUL-2017, the patient was vaccinated with ZOSTAVAX lot # N012492, expiration date 17-MAR-2018 (dose and route of administration were not provided) for vaccination, which was reconstituted with sterile diluent, lot # N001534, expiration date 30-JUL-2019. On an unknown date in 2017 (reported as after receiving ZOSTAVAX, the patient experienced an unspecified rash at the injection site. The patient did not receive any treatment for the event. The outcome of the event was reported as not recovered/not resolved. Additional information has been requested.
On 3/12/21 pt received one dose of the Moderna COVID vaccine. Pt reports that on 3/13/21 his chronic back pain was so bad that he could not walk. Patient is not a great historian, and his story is confusing.  Patient says that after 3/13 he spoke to his orthopedic surgeon, who told him to get a Pfizer COVID vaccine next time. (Calls to the provider's office refute this story, office staff say the patient was told to not get any second doses).  Patient came to a walk-in vaccine clinic on 3/30/21 and received a Pfizer COVID vaccine (lot #ER8732), 18 days after his Moderna dose. Patient does not report any adverse effects from the second vaccine.   CDC was contacted through their NIPINFO form, and they confirmed that the patient does not need any additional doses.
Fever blister erupted about 12 hours after injection.  Never had a fever blister in past
pt positive for COVID on 9/20; received monoclonal antibodies; was brought to hosp via EMS for worsening SOB and confusion; Decadron, Lovenox, Remdesivir; O2 supplementation of High-Flow O2 via NC plus NRB; eventually required intubation; declining respiratory status and overall progress; pt was made DNR and eventually comfort measures; he passed away in the hosp
Patient came to the pharmacist for help about 5 minutes after his immunization, he was shaky. When the pharmacist came out to check on him, he collapsed. He was shaky, sweating, complaining of being on fire. He was given a bottle of water after asking for water.  The patient then alternately complained of having trouble breathing and feeling better for several cycles. The EMS arrived about 20 minutes after being called and the pharmacist left the patient in the care of the EMT's.  EMS left about 1/2 an hour later, then the patient's wife showed up to take him home.  After 6pm, the patient was checked on by the pharmacist and he was doing well at that time.